FDG-PET Imaging for Hodgkin and Diffuse Large B-Cell Lymphoma-An Updated Overview

Cancers
Conrad-Amadeus VoltinDirk Hellwig

Abstract

Since the mid-1990s, 18F-fluorodeoxglucose (FDG)-positron emission tomography (PET) in combination with computed tomography has come to play a prominent role in the management of malignant lymphomas. One of the first PET applications in oncology was the detection of lymphoma manifestations at staging, where it has shown high sensitivity. Nowadays, this imaging modality is also used during treatment to evaluate the individual chemosensitivity and adapt further therapy accordingly. If the end-of-treatment PET is negative, irradiation in advanced-stage Hodgkin lymphoma patients can be safely omitted after highly effective chemotherapy. Thus far, lymphoma response assessment has mainly been performed using visual criteria, such as the Deauville five-point scale, which became the international standard in 2014. However, novel measures such as metabolic tumor volume or total lesion glycolysis have recently been recognized by several working groups and may further increase the diagnostic and prognostic value of FDG-PET in the future.

References

Jun 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G P Canellos
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN International Non-Hodgkin's Lymphoma Prognostic Factors Project
Mar 16, 2001·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M de WitD K Hossfeld
Dec 19, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G JerusalemG Fillet
Sep 30, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P RaananiE Even-Sapir
Jan 30, 2008·The Lancet Oncology·Michael PfreundschuhUNKNOWN German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)
Jun 14, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R L ElstromR K J Brown
Mar 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pier Luigi ZinzaniMichele Baccarani
Jun 24, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Richard L WahlMartin A Lodge
Jun 23, 2009·Leukemia & Lymphoma·Michel MeignanCorinne Haioun
Nov 11, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H MocikovaM Trneny
Mar 6, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Gerard Moulin-RomseeJean-Luc Moretti
Sep 8, 2010·The New England Journal of Medicine·Andreas EngertVolker Diehl
Apr 13, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christian SteidlRandy D Gascoyne
Aug 10, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sandra PurzRegine Kluge
Nov 15, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tarec Christoffer El-GalalyMartin Hutchings
Feb 5, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gerhard HeldMichael Pfreundschuh
Feb 26, 2014·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Cédric RossiRené-Olivier Casasnovas
Feb 27, 2014·European Journal of Nuclear Medicine and Molecular Imaging·Michal Weiler-SagieOra Israel
May 7, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carsten KobeMarkus Dietlein
Aug 13, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonT Andrew Lister
Sep 13, 2014·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Juliano J CerciRobert Carr
Apr 1, 2015·Theranostics·Hans Jürgen WesterMarkus Schwaiger
Apr 23, 2015·The New England Journal of Medicine·John RadfordSally Barrington
May 16, 2015·Cancer Research·Sandra HeskampOtto C Boerman
Jul 8, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christoph MamotGiovanni Martinelli
Sep 1, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H TillyUNKNOWN ESMO Guidelines Committee
Feb 24, 2016·European Journal of Nuclear Medicine and Molecular Imaging·N George MikhaeelSally F Barrington
Mar 24, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M AlzahraniD Villa
Jun 23, 2016·The New England Journal of Medicine·Peter JohnsonSally Barrington
Mar 16, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marc P E AndréJohn Raemaekers
Apr 6, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A YounesV E Seshan

❮ Previous
Next ❯

Citations

Jun 12, 2020·Cancers·Laura Evangelista, Stefano Fanti
Jul 24, 2020·Current Opinion in Urology·Maarten L DonswijkPim J van Leeuwen
Oct 25, 2020·International Journal of Clinical Oncology·Shintaro YamanakaYoshihiro Yakushijin
May 15, 2021·Frontiers in Cell and Developmental Biology·Jiarui LiuXin Wang
Jun 21, 2021·European Journal of Radiology·Lucia ZanoniStefano Fanti

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
irradiating

Software Mentioned

PETAL
eBEACOPP
OPTIMAL

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nuklearmedizin. Nuclear Medicine
Carsten KobeRegine Kluge
Radiologic Clinics of North America
Heiko Schoder, Craig H Moskowitz
Contemporary Oncology Współczesna Onkologia
Edyta SuboczMirosław Dziuk
Critical Reviews in Oncology/hematology
Martin HutchingsLena Specht
© 2021 Meta ULC. All rights reserved